Public-registry site landscape for NCT04819373, a Tumor, Solid study sponsored by Eikon Therapeutics. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04819373 (registry record) |
| Sponsor | Eikon Therapeutics |
| Condition(s) | Tumor, Solid |
| Phase | PHASE2 |
| Listed sites | 1 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT04819373 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →